ECSP972241A - INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USE - Google Patents
INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USEInfo
- Publication number
- ECSP972241A ECSP972241A ECSP972241A ECSP972241A EC SP972241 A ECSP972241 A EC SP972241A EC SP972241 A ECSP972241 A EC SP972241A EC SP972241 A ECSP972241 A EC SP972241A
- Authority
- EC
- Ecuador
- Prior art keywords
- alkyl
- phenyl
- oco
- substituted phenyl
- naftile
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El invento se refiere a un compuesto de la fórmula I (gráfico), en la que; R1 es -H, -OH, -O(alquilo C1-C4), -OCOAr donde Ar es fenilo o fenilo sustituído, -O(CO)Oar donde Ar es fenilo o fenilo sustituído, -OCO(alquilo C1-C6), -O(CO) o (alquilo C1-C6) u OSO2(alquilo C4-C6); R2 es -H, F, -Cl, -OH, -O(alquilo C1-C4), -OCOAr donde Ar es fenilo o fenilo sustituído, -O(CO)OAr donde Ar es fenilo o fenilo sustituído, -OCO(alquilo C1-C6), -O(CO) o (alquilo C1-C6) u -OSO2 (alquilo C4-C6); R3 y R4 son independientemente, -H, -F, -CL, CH3, -OH, -O(alquilo C1-C4), -OCO Ar donde Ar es fenilo o fenilo sustituido, -OCO(alquilo C1-C6), -O(CO) o (alquilo C1-C6) u OSO2 (alquilo C4-C6), con la condición de que R3 y R4 no pueden ser, ambos, hidrógeno; n es 2 ó 3 y; R5 es 1-piperidinilo, 1-pirrolidinilo, metil-1-pirrolidinilo, dimetil-1 pirrolidinilo, 4-morfolino, dimetilamino, dietilamino o 1-hexametilenimino; o una sal o solvato farmacéuticamente aceptable al mismo.The invention relates to a compound of formula I (graph), in which; R1 is -H, -OH, -O (C1-C4 alkyl), -OCOAr where Ar is phenyl or substituted phenyl, -O (CO) Oar where Ar is phenyl or substituted phenyl, -OCO (C1-C6 alkyl), -O (CO) or (C1-C6 alkyl) or OSO2 (C4-C6 alkyl); R2 is -H, F, -Cl, -OH, -O (C1-C4 alkyl), -OCOAr where Ar is phenyl or substituted phenyl, -O (CO) OAr where Ar is phenyl or substituted phenyl, -OCO (alkyl C1-C6), -O (CO) or (C1-C6 alkyl) or -OSO2 (C4-C6 alkyl); R3 and R4 are independently, -H, -F, -CL, CH3, -OH, -O (C1-C4 alkyl), -OCO Ar where Ar is phenyl or substituted phenyl, -OCO (C1-C6 alkyl), - Or (CO) or (C1-C6 alkyl) or OSO2 (C4-C6 alkyl), provided that R3 and R4 cannot both be hydrogen; n is 2 or 3 and; R5 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1 pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereto.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972241 ECSP972241A (en) | 1997-08-27 | 1997-08-27 | INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972241 ECSP972241A (en) | 1997-08-27 | 1997-08-27 | INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972241A true ECSP972241A (en) | 1998-11-30 |
Family
ID=42043072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972241 ECSP972241A (en) | 1997-08-27 | 1997-08-27 | INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972241A (en) |
-
1997
- 1997-08-27 EC ECSP972241 patent/ECSP972241A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0703228T3 (en) | Naphthyl compounds, intermediates, processes, compositions containing them | |
| CR10145A (en) | USEFUL TROPANAN DERIVATIVES IN THERAPY (DIVISIONAL EXP. 6800) | |
| AR003930A1 (en) | PROCEDURE FOR PREPARING COMPOUNDS OF 2-PHENYL-3-PHENOXY OR PHENYLTIO-BENZOTIOFEN AND PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS OF EXCLUSIVE APPLICATION IN SUCH PROCEDURE AND METHOD FOR PREPARING INTERMEDIATE COMPOUNDS | |
| BR9713460A (en) | Liquid cleaning composition, and liquid bleaching composition. | |
| HUP0302487A2 (en) | New mandelic acid derivatives and their use as throbin inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| MX9600743A (en) | Compounds, intermediates, compositions, and methods. | |
| CO4920221A1 (en) | NAFTILE COMPOUNDS, INTERMEDIATES, COMPOSITIONS AND PROCEDURES FOR USE | |
| DE69707611T2 (en) | Dihydronaphthalene and naphthalene derivatives, intermediates, compositions and their manufacturing processes | |
| AR007012A1 (en) | 2-PHENYL-3-BENZOIL-BENZOTIOPHENES COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS FOR THE TREATMENT OF POSTMENOPAUSIC SYNDROME, INHIBITION OF CANCER STROGEN-DEPENDENT CANCER, OTHER PATHOLOGIES | |
| DE69726513D1 (en) | Benzo [B] thiophene compounds, intermediates, process, compositions and method | |
| IL113966A0 (en) | Processes and intermediates for the preparation ofpiperazine derivatives | |
| HUP0004413A2 (en) | Use of 2-aryl-3-aroyl-benzo[b]thiophenes for producing medicaments useful treatment of estrogen deprivation syndrome | |
| ECSP972241A (en) | INTERMEDIATE NAFTILE COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR USE | |
| ES2148681T3 (en) | PHARMACEUTICAL BENZOTIOFEN COMPOUNDS. | |
| CO4750819A1 (en) | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 | |
| ATE215536T1 (en) | BENZOFLUORENE COMPOUNDS, INTERMEDIATE COMPOUNDS, COMPOSITIONS AND METHODS | |
| CO5011067A1 (en) | DERIVATIVES OF BIFENYL AS PHARMACEUTICAL PRODUCTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ATE236152T1 (en) | BENZOTHIOPHENE COMPOUNDS, INTERMEDIATE PRODUCTS, METHOD AND METHOD OF USE | |
| WO2002040005A3 (en) | Blockade of sodium channels by phenol derivatives | |
| ECSP972238A (en) | AMORPHOUS BENZOTIOFENS, PROCEDURES FOR ITS PREPARATION AND PROCEDURE FOR ITS USE | |
| ECSP961673A (en) | BENZOTIOFEN COMPOUNDS, INTERMEDIATE PRODUCTS, COMPOSITIONS AND PROCEDURES | |
| TW254937B (en) | Benzocycloheptene derivative and process for preparation thereof | |
| NO973470L (en) | Procedure for reducing serum calcium levels |